Meanwhile, USP36 expression was negatively associated with the sensitivity of cancer cells to the anti-cancer drug olaparib, as evidenced by analysis of the data from the CellMinerCDB (37) in 43 ovarian cancer cell lines (Figure 7F). This evidence concerns the gene USP36 and ovarian carcinoma.